Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19.
Woodruff MC, Ramonell RP, Nguyen DC, Cashman KS, Saini AS, Haddad NS, Ley AM, Kyu S, Howell JC, Ozturk T, Lee S, Suryadevara N, Case JB, Bugrovsky R, Chen W, Estrada J, Morrison-Porter A, Derrico A, Anam FA, Sharma M, Wu HM, Le SN, Jenks SA, Tipton CM, Staitieh B, Daiss JL, Ghosn E, Diamond MS, Carnahan RH, Crowe JE Jr, Hu WT, Lee FE, Sanz I. Woodruff MC, et al. Among authors: morrison porter a. Nat Immunol. 2020 Dec;21(12):1506-1516. doi: 10.1038/s41590-020-00814-z. Epub 2020 Oct 7. Nat Immunol. 2020. PMID: 33028979 Free PMC article.
One-Stop Serum Assay Identifies COVID-19 Disease Severity and Vaccination Responses.
Haddad NS, Nguyen DC, Kuruvilla ME, Morrison-Porter A, Anam F, Cashman KS, Ramonell RP, Kyu S, Saini AS, Cabrera-Mora M, Derrico A, Alter D, Roback JD, Horwath M, O'Keefe JB, Wu HM, Wong AI, Dretler AW, Gripaldo R, Lane AN, Wu H, Chu HY, Lee S, Hernandez M, Engineer V, Varghese J, Patel R, Jalal A, French V, Guysenov I, Lane CE, Mengistsu T, Normile KE, Mnzava O, Le S, Sanz I, Daiss JL, Lee FE. Haddad NS, et al. Among authors: morrison porter a. Immunohorizons. 2021 May 17;5(5):322-335. doi: 10.4049/immunohorizons.2100011. Immunohorizons. 2021. PMID: 34001652
Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 Infection.
Haddad NS, Nguyen DC, Kuruvilla ME, Morrison-Porter A, Anam F, Cashman KS, Ramonell RP, Kyu S, Saini AS, Cabrera-Mora M, Derrico A, Alter D, Roback JD, Horwath M, O'Keefe JB, Wu HM, Ian Wong AK, Dretler AW, Gripaldo R, Lane AN, Wu H, Lee S, Hernandez M, Engineer V, Varghese J, Le S, Sanz I, Daiss JL, Eun-Hyung Lee F. Haddad NS, et al. Among authors: morrison porter a. bioRxiv. 2020 Dec 6:2020.12.04.410589. doi: 10.1101/2020.12.04.410589. Preprint. bioRxiv. 2020. PMID: 33299998 Free PMC article.
Delayed Kinetics of IgG, but Not IgA, Antispike Antibodies in Transplant Recipients following SARS-CoV-2 Infection.
Cravedi P, Ahearn P, Wang L, Yalamarti T, Hartzell S, Azzi Y, Menon MC, Jain A, Billah M, Fernandez-Vina M, Gebel HM, Woodle ES, Haddad NS, Morrison-Porter A, Lee FE, Sanz I, Akalin E, Girnita A, Maltzman JS. Cravedi P, et al. Among authors: morrison porter a. J Am Soc Nephrol. 2021 Oct 1;32(12):3221-30. doi: 10.1681/ASN.2021040573. Online ahead of print. J Am Soc Nephrol. 2021. PMID: 34599041
Reduced COVID-19 Vaccine Response in Patients Treated with Biologic Therapies for Asthma.
Runnstrom MC, Morrison-Porter A, Ravindran M, Quehl H, Ramonell RP, Woodruff M, Patel R, Kim C, Haddad NS, Lee FE. Runnstrom MC, et al. Among authors: morrison porter a. Am J Respir Crit Care Med. 2022 May 15;205(10):1243-1245. doi: 10.1164/rccm.202111-2496LE. Am J Respir Crit Care Med. 2022. PMID: 35180044 No abstract available.
Dominant extrafollicular B cell responses in severe COVID-19 disease correlate with robust viral-specific antibody production but poor clinical outcomes.
Woodruff M, Ramonell R, Cashman K, Nguyen D, Saini A, Haddad N, Ley A, Kyu S, Howell JC, Ozturk T, Lee S, Chen W, Estrada J, Morrison-Porter A, Derrico A, Anam F, Sharma M, Wu H, Le S, Jenks S, Tipton CM, Hu W, Lee FE, Sanz I. Woodruff M, et al. Among authors: morrison porter a. medRxiv. 2020 Jun 22:2020.04.29.20083717. doi: 10.1101/2020.04.29.20083717. Preprint. medRxiv. 2020. PMID: 32511635 Free PMC article.